Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3785 - 3792 of 11617 results
Recent USPTO Report Suggests Greater Consistency and Predictability in Patent-Ineligible Subject Matter Rejections
April 28, 2020| Blog| Viewpoint
The Impact of the CARES Act on 401(k) and Other Defined Contribution Plans
April 28, 2020| Blog| Viewpoint
New Updates to Trusted Traveler Programs
April 28, 2020| Blog| Viewpoint
Strategic Considerations for Obtaining a Foreign Filing License in China
April 27, 2020| Blog| Viewpoint
Federal Circuit Finds IPRs Can Circumvent Assignor Estoppel
April 27, 2020| Blog| Viewpoint
How the CARES Act Affects Patent Related Deadlines
April 27, 2020| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.